Save on Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate with Coupons, Discounts & Savings Programs

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate is available as an oral tablet containing 150 mg of elvitegravir, 150 mg of cobicistat, 200 mg of emtricitabine, and 300 mg of tenofovir disoproxil fumarate.

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate is a 4 drug combination that is used to treat HIV-1 infection in adult patients.

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate contains an integrase inhibitor (elvitegravir) and two nucleoside reverse transcriptase inhibitors (NRTIs) (emtricitabine, tenofovir). These 3 medications work together to prevent the virus from making copies of itself in your body. The booster medication (cobicistat) slows the metabolism of elvitegravir (Vitekta) and raises the level in the body.

The typical dose of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate is one tablet by mouth once daily with food.

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. Coadministration of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate is contraindicated with drugs that are highly dependent on CYP3A for clearance and drugs that strongly induce CYP3A.

Common side effects of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate:

• Nausea
• Diarrhea
• Abnormal, strange dreams
• Headache

Serious side effects are rare with Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate. Contact your healthcare provider immediately if you experience any of the following:

• New onset or worsening kidney or liver problems
• Worsening hepatitis B
• Lower bone density
• Immune reconstitution syndrome

The following medications may interact with Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate:

• Other antiretroviral medications used to treat HIV-1 infections
• Drugs metabolized by CYP3A or CYP2D6

Various FDA-approved generic manufacturers

It is not known whether this medication is safe for you and your unborn baby during pregnancy and should only be used if the potential benefit justifies the potential risk. Talk to your doctor if you are already pregnant or if you have plans on becoming pregnant. They will recommend what is best for you.

• Stribild